| Primary |
| Angina Pectoris |
54.8% |
| Drug Use For Unknown Indication |
12.3% |
| Product Used For Unknown Indication |
12.1% |
| Coronary Artery Disease |
4.5% |
| Hypertension |
3.0% |
| Myocardial Ischaemia |
2.4% |
| Type 2 Diabetes Mellitus |
2.1% |
| Chest Pain |
1.3% |
| Atrial Fibrillation |
1.2% |
| Diabetes Mellitus |
0.9% |
| Angina Unstable |
0.8% |
| Cardiac Failure |
0.7% |
| Asthma |
0.7% |
| Cardiac Disorder |
0.7% |
| Cardiac Failure Congestive |
0.6% |
| Blood Cholesterol Increased |
0.5% |
| Dyslipidaemia |
0.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.3% |
| Urinary Tract Infection |
0.3% |
| Blood Pressure |
0.3% |
|
| Death |
17.3% |
| Nausea |
8.7% |
| Tremor |
7.5% |
| Syncope |
7.0% |
| Vomiting |
5.8% |
| Rash |
5.3% |
| Rhabdomyolysis |
5.3% |
| Torsade De Pointes |
5.3% |
| Dizziness |
4.8% |
| Ventricular Tachycardia |
4.6% |
| Therapeutic Response Unexpected |
3.8% |
| Weight Decreased |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Chest Pain |
2.9% |
| Sudden Death |
2.9% |
| Fatigue |
2.6% |
| Vision Blurred |
2.6% |
| Dyspnoea |
2.4% |
| Headache |
2.4% |
| Angina Pectoris |
2.2% |
|
| Secondary |
| Angina Pectoris |
26.9% |
| Product Used For Unknown Indication |
23.6% |
| Drug Use For Unknown Indication |
16.5% |
| Hypertension |
4.4% |
| Type 2 Diabetes Mellitus |
4.1% |
| Atrial Fibrillation |
2.8% |
| Blood Cholesterol Increased |
2.5% |
| Coronary Artery Disease |
2.5% |
| Cardiac Disorder |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Myocardial Ischaemia |
1.7% |
| Urinary Tract Infection |
1.7% |
| Asthma |
1.6% |
| Angina Unstable |
1.4% |
| Cardiac Failure Congestive |
1.3% |
| Gout |
1.1% |
| Cerebrovascular Accident Prophylaxis |
0.8% |
| Chest Pain |
0.8% |
| Hyperlipidaemia |
0.8% |
| Cardiomyopathy |
0.6% |
|
| Rhabdomyolysis |
20.2% |
| Syncope |
9.2% |
| Vomiting |
8.4% |
| Drug Interaction |
5.9% |
| Nausea |
5.9% |
| Weight Decreased |
5.0% |
| Angina Pectoris |
4.2% |
| Hypotension |
4.2% |
| Malaise |
4.2% |
| Rash |
4.2% |
| Urinary Tract Infection |
4.2% |
| Dizziness |
3.4% |
| Tremor |
3.4% |
| Chest Discomfort |
2.5% |
| Convulsion |
2.5% |
| Electrocardiogram Qt Prolonged |
2.5% |
| Fatigue |
2.5% |
| Hallucination, Visual |
2.5% |
| Hepatic Enzyme Increased |
2.5% |
| Hyperhidrosis |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.0% |
| Drug Use For Unknown Indication |
12.6% |
| Hypertension |
8.1% |
| Cardiac Disorder |
7.8% |
| Angina Pectoris |
3.8% |
| Blood Cholesterol Increased |
3.3% |
| Coronary Artery Disease |
3.0% |
| Atrial Fibrillation |
2.5% |
| Pain |
2.4% |
| Nuclear Magnetic Resonance Imaging |
2.2% |
| Diabetes Mellitus |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Prophylaxis |
2.0% |
| Type 2 Diabetes Mellitus |
1.8% |
| Blood Cholesterol |
1.6% |
| Chest Pain |
1.5% |
| Blood Pressure |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Asthma |
1.2% |
| Depression |
1.2% |
|
| Vomiting |
8.6% |
| Flushing |
7.8% |
| Myocardial Infarction |
7.8% |
| Tremor |
7.8% |
| Pruritus |
7.0% |
| Death |
6.2% |
| Drug Ineffective |
6.2% |
| Weight Decreased |
5.4% |
| Transient Ischaemic Attack |
4.3% |
| Nausea |
3.9% |
| Pain |
3.9% |
| Pain In Extremity |
3.9% |
| Pneumonia |
3.9% |
| Headache |
3.5% |
| Paraesthesia |
3.5% |
| Product Quality Issue |
3.5% |
| Visual Impairment |
3.5% |
| Cardiac Failure Congestive |
3.1% |
| Chest Pain |
3.1% |
| Nephrogenic Systemic Fibrosis |
3.1% |
|
| Interacting |
| Angina Pectoris |
22.2% |
| Coronary Artery Disease |
13.0% |
| Product Used For Unknown Indication |
13.0% |
| Drug Use For Unknown Indication |
7.4% |
| Hypercholesterolaemia |
7.4% |
| Atrial Fibrillation |
5.6% |
| Cardiac Failure |
5.6% |
| Hypertension |
5.6% |
| Prophylaxis Against Transplant Rejection |
3.7% |
| Renal Transplant |
3.7% |
| Thrombosis Prophylaxis |
3.7% |
| Antiplatelet Therapy |
1.9% |
| Back Pain |
1.9% |
| Hip Arthroplasty |
1.9% |
| Hyperlipidaemia |
1.9% |
| Myocardial Ischaemia |
1.9% |
|
| Rhabdomyolysis |
33.3% |
| Drug Interaction |
22.2% |
| Hypersensitivity |
11.1% |
| Memory Impairment |
11.1% |
| Renal Failure Acute |
11.1% |
| Laryngeal Cancer |
5.6% |
| Tremor |
5.6% |
|
